SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031239
Filing Date
2022-11-10
Accepted
2022-11-10 08:30:30
Documents
44
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 835222
2 ex31-1.htm EX-31.1 13225
3 ex31-2.htm EX-31.2 13243
4 ex32-1.htm EX-32.1 8898
  Complete submission text file 0001493152-22-031239.txt   2653259

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE aneb-20220930.xsd EX-101.SCH 19798
6 XBRL CALCULATION FILE aneb-20220930_cal.xml EX-101.CAL 26257
7 XBRL DEFINITION FILE aneb-20220930_def.xml EX-101.DEF 52995
8 XBRL LABEL FILE aneb-20220930_lab.xml EX-101.LAB 174358
9 XBRL PRESENTATION FILE aneb-20220930_pre.xml EX-101.PRE 129347
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 231151
Mailing Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734
Business Address 1415 RANCH ROAD 629 SOUTH, SUITE 201 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-40388 | Film No.: 221375115
SIC: 2834 Pharmaceutical Preparations